Manning & Napier Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Manning & Napier Advisors's BMY Position: Q2 2026 in Review
Manning & Napier Advisors increased its Bristol-Myers Squibb (BMY) stake by 0.87% in Q2 2026, buying an estimated $91.1K and bringing the position to 184,742 shares worth $10.8M. The position accounts for 0.14% of the portfolio, ranked #95.
Manning & Napier Advisors first reported a position in BMY in Q2 2013 and has held it in 17 quarters since. The position peaked at $179M in Q4 2016. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Manning & Napier Advisors held 184,742 shares of Bristol-Myers Squibb worth $10.8M as of Q2 2026.
- Manning & Napier Advisors bought 1,587 Bristol-Myers Squibb shares in Q2 2026, an estimated $91.1K.
- Bristol-Myers Squibb made up 0.14% of Manning & Napier Advisors's portfolio in Q2 2026, its #95 holding.
- Manning & Napier Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 17 quarters since.
- Manning & Napier Advisors's Bristol-Myers Squibb position peaked at $179M in Q4 2016.
- 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.